The company started selling a compounded version of semaglutide last year, when the drug was still on the FDA's shortage list
A brief word on retatrutide Its a triple agonist hitting GLP-1, GIP, and glucagon receptors and the glucagon component is what sets it apart
Results: During a median follow-up of 4.9 years, 876 (45.3%) patients developed intrahepatic HCC recurrence
Frequently asked questions Does resM GLP-1 postbiotic actually contain GLP-1
Unlike emerging markets where growth is volume-led, USA growth is driven by indication expansion into cardiovascular risk reduction and intensifying competition between semaglutide and tirzepatide
With altRx, you get more than a medicationyou get a guided, supportive pathway to long lasting results